A detailed history of Eaton Vance Management transactions in Nevro Corp stock. As of the latest transaction made, Eaton Vance Management holds 22,410 shares of NVRO stock, worth $188,692. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,410
Previous 22,410 -0.0%
Holding current value
$188,692
Previous $982,000 6.31%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$40.85 - $77.67 $563,403 - $1.07 Million
-13,792 Reduced 38.1%
22,410 $982,000
Q1 2022

May 16, 2022

BUY
$59.95 - $92.06 $681,091 - $1.05 Million
11,361 Added 45.73%
36,202 $2.62 Million
Q4 2021

Feb 14, 2022

BUY
$81.07 - $121.29 $24,645 - $36,872
304 Added 1.24%
24,841 $1.99 Million
Q3 2020

Nov 13, 2020

BUY
$114.09 - $145.51 $1.7 Million - $2.17 Million
14,896 Added 154.51%
24,537 $3.42 Million
Q2 2020

Aug 13, 2020

BUY
$89.45 - $129.85 $862,387 - $1.25 Million
9,641 New
9,641 $1.15 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $298M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.